Eric Crombez

Hoofd Techniek/Wetenschap/O&O bij ULTRAGENYX PHARMACEUTICAL INC.

Vermogen: 2 M $ op 30-04-2024

Health Technology

Consumer Services

Retail Trade

Actieve functies van Eric Crombez

Bedrijven	Functie	Begin	Einde
ULTRAGENYX PHARMACEUTICAL INC.	Hoofd Techniek/Wetenschap/O&O	01-05-2023	-
ULTRAGENYX PHARMACEUTICAL INC.	Corporate Officer/Principal	01-11-2017	01-05-2023
Automobiles Vienne Sud Automobiles Vienne Sud Specialty StoresRetail Trade Part of ECL SAS, Automobiles Vienne Sud is a company that provides automobile dealership services. The company is based in Vienne, France. Automobiles Vienne Sud was acquired by ECL SAS on November 24, 2021.	Directeur/Bestuurslid	-	-

Bedrijven	Functie	Begin	Einde
DIMENSION THERAPEUTICS INC	Hoofd Techniek/Wetenschap/O&O	01-12-2014	01-11-2017
Shire LLC Shire LLC Pharmaceuticals: MajorHealth Technology Shire LLC provides pharmaceutical services. The company was founded in 2004 and is headquartered in Florence , KY.	Hoofd Techniek/Wetenschap/O&O	01-01-2007	01-01-2014
University of California, Los Angeles	Corporate Officer/Principal	-	-

University of Michigan	Undergraduate Degree
The Wayne State University School of Medicine	Doctorate Degree

Internationaal

Verenigde Staten	7
Frankrijk	2

Operationeel

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	2
Undergraduate Degree	1

Sectoraal

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
ULTRAGENYX PHARMACEUTICAL INC.	Health Technology

Bedrijven in privébezit	3
Shire LLC Shire LLC Pharmaceuticals: MajorHealth Technology Shire LLC provides pharmaceutical services. The company was founded in 2004 and is headquartered in Florence , KY.	Health Technology
Automobiles Vienne Sud Automobiles Vienne Sud Specialty StoresRetail Trade Part of ECL SAS, Automobiles Vienne Sud is a company that provides automobile dealership services. The company is based in Vienne, France. Automobiles Vienne Sud was acquired by ECL SAS on November 24, 2021.	Retail Trade
Dimension Therapeutics, Inc. Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA.	Health Technology